Skip to main content

Table 6 Multivariate Cox analysis of factors affecting late recurrent EOC

From: Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer

 

B

SE

Wald

HR (95% CI)

P

Treatment course

1.018

0.252

16.279

2.768(1.688–4.539)

0.000

Apatinib

−0.968

0.285

11.552

0.380(0.217–0.644)

0.001

Recurrent lesions

0.626

0.305

4.206

1.870(1.028–3.403)

0.04

Surgery

0.156

0.273

0.326

1.168(0.685–1.994)

0.568

CA125 level

0.009

0.274

0.001

1.009(0.590–1.726)

0.974

Ascites

−0.170

0.248

0.326

0.844(0.518–1.373)

0.494